Neutral
OS Therapies Gains EMA Rolling Review for OST-HER2
OS Therapies has announced that the European Medicines Agency (EMA) has initiated a rolling review for its OST-HER2 conditional marketing authorizatio...
OSTX
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (0)
Neutral (1)
Bearish (0)
Latest OSTX News
Neutral
Research OSTX on:
Ad Space